Pfizer Inc – Page 4 – MOSAEC

Antibiotic Shortage Could Fuel Rise in Syphilis Rates

Centers for Disease Control and Prevention Drug Resistance (Microbial) Drugs (Pharmaceuticals) Factories and Manufacturing Medicine and Health Pfizer Inc Sexually Transmitted Diseases Shortages Syphilis

Antibiotic Shortage Could Fuel Rise in Syphilis Rates

The primary drug used to treat the sexually transmitted infection could be scarce into next year, Pfizer warns.

By Benjamin Ryan

Federal Officials Hatch a Three-Pronged Defense Against Another ‘Tripledemic’

Coronavirus (2019-nCoV) Elderly GSK PLC Guillain-Barre Syndrome Influenza Pfizer Inc Respiratory Syncytial Virus (RSV) Vaccination and Immunization Winter (Season)

Federal Officials Hatch a Three-Pronged Defense Against Another ‘Tripledemic’

This fall, Americans will be urged to get shots against the flu, Covid and, if they’re older, R.S.V.

By Apoorva Mandavilli

FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant

Centers for Disease Control and Prevention Coronavirus (2019-nCoV) Coronavirus Omicron Variant Food and Drug Administration Moderna Inc Novavax Inc Pfizer Inc United States Vaccination and Immunization

FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant

An F.D.A. advisory panel told manufacturers to aim the latest coronavirus vaccine for the fall at the dominant SARS-CoV-2 variant.

By Christina Jewett

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Centers for Disease Control and Prevention Drugs (Pharmaceuticals) Elderly Food and Drug Administration GSK PLC Guillain-Barre Syndrome Pfizer Inc Respiratory Syncytial Virus (RSV) Vaccination and Immunization Viruses Winter (Season)

FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.

By Christina Jewett